一项减少社区获得性肺炎抗生素治疗过度疗程的多中心管理干预
该多中心准实验研究评估了为期6个月的前瞻性管理干预(更新指南、教育、每日审核反馈)对住院社区获得性肺炎(CAP)患者抗生素总疗程的影响。共纳入600例患者(历史对照组307例,干预组293例)。干预提高了指南依从性(42% vs 5.6%,P<0.001),缩短了中位疗程(6天 vs 9天,P<0.001),且未对死亡率、再入院等临床结局产生不利影响。
要点
- 管理干预提高疗程指南依从性(42% vs 5.6%,P<0.001)。
- 干预组中位抗生素疗程较对照组缩短(6天 vs 9天,P<0.001)。
- 死亡率、再入院等30天内临床结局两组无差异。
核心结论
- 住院CAP患者的多中心管理干预减少了抗生素总疗程并提高了指南依从性,未对患者结局产生不利影响。
研究设计与样本
- 多中心准实验研究,纳入600例住院CAP患者(历史对照组307例,管理干预组293例),干预为期6个月。
主要发现
- 管理干预组指南依从性为42%,历史对照组为5.6%(P<0.001)。
- 管理干预组每患者中位抗生素疗程为6天,历史对照组为9天(P<0.001)。
- 出院30天内死亡率、肺炎再入院、因肺炎就诊急诊/诊所及艰难梭菌感染发生率两组间无差异。
关键数值与推荐
- IDSA/ATS CAP指南推荐对临床稳定且快速退热的患者给予5天疗程。
- 所有中心更新机构CAP指南以促进符合IDSA/ATS的疗程,并提供教育及每日审核反馈以给出患者特异性疗程建议。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The increased emphasis on pneumonia-related performance measures and patient outcomes has led hospitals to implement multifaceted approaches to quickly identify patients with community-acquired pneumonia (CAP), start timely therapy and reduce readmission. However, there has been minimal focus on duration of therapy (DOT) and patients often receive prolonged antibiotic courses. The IDSA and American Thoracic Society (IDSA/ATS) CAP guidelines recommend 5 days of therapy for clinically stable patients that quickly defervesce and stewardship teams are well positioned to influence prescribing practices. OBJECTIVES: Determine the impact of a prospective stewardship intervention on total antibiotic DOT and associated clinical outcomes in hospitalized patients with CAP. METHODS: This multicentre, quasi-experimental study evaluated three concurrent interventions over a 6 month period to promote appropriate DOT. All centres updated institutional CAP guidelines to promote IDSA/ATS-concordant DOT, provided education and conducted daily audit and feedback with intervention to provide patient-specific DOT recommendations. RESULTS: A total of 600 patients with CAP were included (307 in the historical control group and 293 in the stewardship intervention group). The stewardship intervention increased compliance with DOT recommendations (42% versus 5.6%, P < 0.001) and reduced the median DOT per patient (6 versus 9 days, P < 0.001). Clinical outcomes, including mortality, readmission with pneumonia, presentation to the emergency centre/clinic with pneumonia and incidence of Clostridium difficile infection within 30 days of discharge, were not different between groups. CONCLUSIONS: This multicentre evaluation of a stewardship intervention in hospitalized CAP patients reduced the total antibiotic DOT and increased guideline-concordant DOT without adversely affecting patient outcomes.
引用
- Foolad F, Huang AM, Nguyen CT, et al. A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia. J Antimicrob Chemother. 2018. PMID: 29462306. doi:10.1093/jac/dky021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。